ArticleJournal for immunotherapy of cancer2023
Correction: Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.